Clinical and business intelligence

David Chen, Shine Technology's director of business development, talks about how HIMSS23 affords him the opportunity to learn more about AI and other cutting-edge digital technologies, and to network with organizations regarding his company's devices.

Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.

Dan Soule, VP of Technology Operations at Health Catalyst, discusses the great strides made in health equity over the last 10 years as well as how AI is finally moving forward with real-world uses.

Nathan Shepard, Azalea's VP of product, discusses how his company is helping rural providers improve patient care and profitability.

Gerry Blass, CEO of ComplyAssistant, and Frank Sinatra, CISO at Newark's University Hospital, discuss the voluntary Health Industry Cybersecurity Practices guide and strategies organizations can implement to ensure compliance.

ONC senior advisor and innovation portfolio lead Stephen Konya, Moffitt Cancer Center VP of digital innovation Santosh Mohan and the Digital Medicine Society CEO Jennifer Goldsack describe their CancerX partnership.

In Chicago, Hal Wolf, CEO of HIMSS, speaks to world digital health leaders about issues to tackle in health equity, population health, cybersecurity and AI.

See our reporters interview healthcare IT thought leaders and deliver news from the 2023 HIMSS Global Health Conference & Exhibition in Chicago.

Ty Vachon, cofounder and CEO of Oatmeal Health, discusses the panel he will moderate at HIMSS23 on the need for realistic expectations of AI use in healthcare and tools that can help ensure AI is safe and effective for patient care.

Healthcare is entering a period of consumerization, assisted by virtual care and AI, according to Transcarent CEO Glen Tullman, who has an upcoming HIMSS23 presentation with HIMSS CEO Hal Wolf.